Takkavatakarn, Kullaya
Oh, Wonsuk
Chan, Lili
Hofer, Ira
Shawwa, Khaled
Kraft, Monica
Shah, Neomi
Kohli-Seth, Roopa
Nadkarni, Girish N.
Sakhuja, Ankit
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK127139, 5K08DK131286)
Article History
Received: 12 February 2024
Accepted: 29 April 2024
First Online: 10 May 2024
Declarations
:
: Consent obtained for use of MIMIC and eICU databases.
: Not applicable.
: GNN is a founder of Renalytix, Pensieve, Verici and provides consultancy services to AstraZeneca, Reata, Renalytix, Siemens Healthineer and Variant Bio, serves a scientific advisory board member for Renalytix and Pensieve. He also has equity in Renalytix, Pensieve and Verici. LC is a consultant for Vifor Pharma INC and has received honorarium from Fresenius Medical Care. All remaining authors have declared no conflicts of interest.